Clinical Trial Detail

NCT ID NCT03395873
Title Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Milton S. Hershey Medical Center
Indications

acute myeloid leukemia

Therapies

Avelumab + Decitabine

Age Groups: adult senior

No variant requirements are available.